Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations. In 2020, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2020 to 2023. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries. The global Preclinical Imaging market was xx million US$ in 2020 and is expected to xx million US$ by the end of 2028, growing at a CAGR of xx% between 2022 and 2028. This report studies the Preclinical Imaging market size (value and volume) by players, regions, product types and end industries, history data 2017-2020 and forecast data 2020-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Preclinical Imaging in these regions, from 2018 to 2028, covering
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
We can also provide the customized separate regional or country-level reports, for the following regions:
The study objectives of this report are:
In this study, the years considered to estimate the market size of Preclinical Imaging are as follows: History Year: 2017-2020 Base Year: 2020 Estimated Year: 2020 Forecast Year 2021 to 2027 This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Preclinical Imaging market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Available Customizations: With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report: Further breakdown of Preclinical Imaging market on basis of the key contributing countries. Detailed analysis and profiling of additional market players.
Choose License Type